Study of the Effects of an Investigational Drug in Adults with Itching Due to Atopic Dermatitis

What we are studying

The purpose of this study is to look at the safety of an investigational drug and to find out if the drug can relieve the symptoms of itching associated with atopic dermatitis, also called eczema.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • Not Hispanic or Latino
  • Ages 18+

Eligibility Criteria

  • Must have a clinical diagnosis of atopic dermatitis for 6 months
  • No history of cancer
  • No history of HIV
  • No alcohol or drug abuse in the past three years

What is involved

  • Participation will last up to 12 weeks and involve up to 11 visits to the study center
  • Vital signs (including body weight)
  • Subject questionnaires
  • Photographs
  • Pregnancy tests
  • Urinalysis
  • Ecgs
  • Blood draws

Compensation

$40 per visit up to a total of $440.

Contact Information

Study Coordinator
Dermatology Clinical Studies
Email
Dermadvertising@wakehealth.edu
Phone
336-716-3775

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.